Related Experiment Video
Updated: May 7, 2026

09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
19.1K
Management and Long-term Follow-up of Vaginal Rhabdomyosarcoma in a 3-Year-Old Female
Lauren Poniatowski1, Katherine Debiec2, Hailey Silverii1
1Department of Urology, Seattle Children's Hospital, Seattle, WA.
Urology
|November 18, 2024
Summary
A young girl with vaginal embryonal rhabdomyosarcoma received chemotherapy and surgery. She has remained cancer-free for 7 years, showing successful treatment outcomes for this rare pediatric cancer.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Gynecologic Oncology
Background:
- Embryonal rhabdomyosarcoma is a rare soft tissue sarcoma affecting children.
- Vaginal rhabdomyosarcoma represents a specific subtype requiring tailored management.
- Treatment protocols often involve a multimodal approach combining chemotherapy and surgery.
Observation:
- A 3-year-old female presented with a vaginal mass.
- Diagnosis confirmed intermediate risk, stage I, group III vaginal embryonal rhabdomyosarcoma.
- Patient underwent chemotherapy per Children's Oncology Group protocol.
Findings:
- Surgical intervention included initial tumor debulking.
- Partial vaginectomy with vaginal reconstruction was performed post-chemotherapy.
- The patient achieved complete remission with no evidence of disease at 7-year follow-up.
Implications:
- This case highlights the efficacy of combined modality treatment for vaginal embryonal rhabdomyosarcoma.
- Successful surgical reconstruction and long-term surveillance are crucial for favorable outcomes.
- The findings support current treatment guidelines for intermediate-risk pediatric rhabdomyosarcoma.

